Which of the following is a non cell cycle specific anticancer drug
**Core Concept**
Non-cell cycle specific anticancer drugs are a class of chemotherapeutic agents that do not target rapidly dividing cells, unlike cell cycle specific drugs. These agents work through different mechanisms, such as interfering with cellular metabolism, inducing apoptosis, or stabilizing DNA.
**Why the Correct Answer is Right**
The correct answer is a topoisomerase inhibitor, specifically etoposide. Topoisomerase inhibitors work by stabilizing the topoisomerase enzyme-DNA complex, preventing DNA replication and transcription. This leads to DNA damage and ultimately cell death. Unlike cell cycle specific drugs, topoisomerase inhibitors can induce cell death in both dividing and non-dividing cells, making them non-cell cycle specific.
**Why Each Wrong Option is Incorrect**
* **Option A:** Cyclophosphamide is a cell cycle specific alkylating agent, which means it targets rapidly dividing cells.
* **Option B:** Doxorubicin is an anthracycline antibiotic that intercalates DNA, but it is still a cell cycle specific agent.
* **Option C:** Paclitaxel is a taxane that stabilizes microtubules, preventing cell division, making it a cell cycle specific agent.
**Clinical Pearl / High-Yield Fact**
Non-cell cycle specific drugs like topoisomerase inhibitors can be effective in treating tumors with low proliferation rates, such as certain types of ovarian cancer.
**Correct Answer:** C. Etoposide is a non-cell cycle specific anticancer drug.